North America Sodium-Glucose Cotransporter Industry Navigating Dynamics Comprehensive Analysis and Forecasts 2025-2033
The North American SGLT2 inhibitor market is booming, driven by rising diabetes prevalence and proven cardiovascular benefits. This comprehensive analysis reveals key market trends, leading companies (Eli Lilly, Janssen, Boehringer Ingelheim), and future growth projections for Jardiance, Farxiga/Forxiga, and Invokana through 2033.